Galderma Group AG (GALDY) 株価予測

Galderma Group AG engages in the provision of science-based premium dermatology solutions. The company is headquartered in Zug, Zug and currently employs 10 full-time employees. The company went IPO on 2024-03-22. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.